Tuesday, 02 January 2024 12:17 GMT

Avai Bio Inc


(MENAFN- Baystreet) 11:32 AM EST - Avai Bio Inc: Together with its joint venture partner Austrianova, announced the successful encapsulation of GMP-quality Klotho-producing cells in the joint venture's signature technology, Cell-in-a-Box® capsules. Avai Bio Inc shares O are trading unchanged at $0.13.

Full Press Release:

MENAFN30092026000212011056ID1111741795



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story